Dow Down 0.25% Nasdaq Down 0.26%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
6.16 Down 0.20(3.14%) Aug 28, 4:00PM EDT
|After Hours : 6.16 0.00 (0.00%) Aug 28, 7:14PM EDT
Prev Close:6.36
Open:6.33
Bid:6.15 x 20000
Ask:6.25 x 3000
1y Target Est:8.72
Beta:1.51
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:6.14 - 6.36
52wk Range:2.15 - 23.00
Volume:4,035,428
Avg Vol (3m):8,088,250
Market Cap:1.15B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIADown 3.14%1.15B
NVSDown 0.30%217.70B
PFEDown 0.37%186.29B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):24.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.15
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback